Mild Traumatic Brain Injury Treatment Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 210

To learn more about this report, request a free sample copy

Mild Traumatic Brain Injury Treatment Market Overview

The report is titled as ‘Mild Traumatic Brain Injury Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the mild traumatic brain injury treatment market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The mild traumatic brain injury treatment market is expected to grow at a significant rate in the near future.

The global mild traumatic brain injury treatment market in 2020 is estimated for more than US$ 65.8 Mn and expected to reach a value of US$ 93.0 Mn by 2028 with a significant CAGR of 4.4%.

Mild Traumatic Brain Injury Treatment Market Dynamics

The increasing number of road accidents, coupled with the growing number of vulnerable aging populations are major factors driving the growth of the global traumatic brain injuries treatment market. For instance, according to data published by the National Health of Mental illness, in January 2018, mental illness is common in the U.S; nearly 46.6 Mn U.S. adults were affected by mental disorders in 2017.

Increasing research activities on diagnosis management, coupled with a new pipeline of drugs are propelling the global traumatic brain injuries treatment market growth. An increase in the research and development by scientists in the U.S. FDA mainly for the study of various biomarkers of brain imaging, bio fluid and physical indicators for detection of traumatic brain injuries (TBI) is in a process which is expected to take a positive turn in the treatment pattern of TBI in patients with severe brain injuries which in turn boosting the growth of the global market.

Mild Traumatic Brain Injury Treatment Pipeline Drugs

Molecular targeted therapies such as BHR-100 (Progesterone Drug) is expected to introduce by BHR Pharma, LLC, rhuEpo, recombinant human erythropoietin is anticipated to propel global market growth over the forecast period.

However, lack of awareness among people, and lack of funding by the government in TBI treatment R&D are anticipated to restrain the growth of the global mild traumatic brain injury treatment market during the next decade. On the other hand, the high cost of treatment and monitoring devices may restrain the growth of the global market. Nevertheless, the large number of clinical trials is conducted worldwide in order to develop effective therapies for TBI which is creating opportunities for growth of the global market.

Mild Traumatic Brain Injury Treatment Market Segmentation

Mild traumatic brain injury treatment market is segmented on the basis of device type, technique, end-user, and by region.

•    By Device Type:

    Imaging Devices

    Computed Tomography Devices

    Magnetic Resonance Imaging

    X-Ray

    Others

    Clinical Examination Devices

    Monitoring Devices

    Invasive Monitoring Devices 

    Non-Invasive Monitoring Devices

•    By Technique:

     Intracranial Pressure Monitoring (ICP) 

    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

•    By End-user:

    Hospitals

    Diagnostic Imaging Centers

    Others 

•    By Region:

    North America

    Europe

    Asia Pacific

    Latin America

    Middle East

    Africa

Mild Traumatic Brain Injury Treatment Market Pipeline Drugs Overview

In the global mild traumatic brain injury treatment market, several drugs are in a pipeline including, Cycloserine, Fosaprepitant, Phenytoin, Sodium oxybate, Epoprostenol, Flortaucipir F-18, and Glyburide. These drugs are in the 0 and 1st phase of investigation respectively. After traumatic brain injury along with wide therapeutic window; Cycloserine improves functional outcome. Fosaprepitant is an intravenously administered antiemetic drug. It is a pro-drug of Aprepitant and aids in prevention of acute as well as delayed nausea and vomiting of chemotherapy treatment.

Mild Traumatic Brain Injury Treatment Market Pipeline Drugs Image

Source: Drugbank, 2019

Mild Traumatic Brain Injury Treatment Market Competitive Landscape

Key players operating in the global mild traumatic brain injury treatment market include TEVA Pharmaceutical Industries Ltd., Neuren Pharmaceuticals Ltd, Tenax Therapeutics, IschemixInc, Grace Laboratories LLC., Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, NeuroScience Pharmaceuticals, Vasopharm GmbH, AmarantusBioScience Holdings, and Banayan Biomarkers Inc.

Regional Segmentation

On the basis of region, the mild traumatic brain injury treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Mild Traumatic Brain Injury Treatment Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Mild Traumatic Brain Injury Treatment market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Mild Traumatic Brain Injury Treatment

•    Advantages of Mild Traumatic Brain Injury Treatment Drugs

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Mild Traumatic Brain Injury Treatment Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Mild Traumatic Brain Injury Treatment Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Mild Traumatic Brain Injury Treatment Market Snapshot

2.4.    Global Mild Traumatic Brain Injury Treatment Market Size and Forecast, 2019–2027

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5.    Global Mild Traumatic Brain Injury Treatment Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Mild Traumatic Brain Injury Treatment Market, By Devices Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Devices Type

3.1.2.    BPS Analysis, By Devices Type

3.2.    Market Revenue (US$Mn) Forecast, By Devices Type

3.2.1.    Imaging Devices

3.2.1.1.    Computed Tomography Devices

3.2.1.2.    Magnetic Resonance Imaging

3.2.1.3.    X-Ray

3.2.1.4.    Others

3.2.2.    Clinical Examination Devices

3.2.3.    Monitoring Devices

3.2.3.1.    Invasive Monitoring Devices 

3.2.3.2.    Non-Invasive Monitoring Devices 

3.3.    Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By Devices Type

4.    Global Mild Traumatic Brain Injury Treatment Market, By Technique

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Technique

4.1.2.    BPS Analysis, By Technique

4.2.    Market Revenue (US$Mn) Forecast, By Technique

4.2.1.    Intracranial Pressure Monitoring (ICP) 

4.2.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2) 

4.3.    Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By Technique

5.    Global Mild Traumatic Brain Injury Treatment Market, By End User

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By End User

5.1.2.    BPS Analysis, By End User

5.2.    Market Revenue (US$Mn) Forecast, By End User

5.2.1.    Hospitals

5.2.2.    Diagnostic Imaging Centers

5.2.3.    Others 

5.3.    Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By End User

6.    Global Mild Traumatic Brain Injury Treatment Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By Region

7.    North America Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Mild Traumatic Brain Injury Treatment Market

7.2.2.    Canada Mild Traumatic Brain Injury Treatment Market

7.3.    North America Mild Traumatic Brain Injury Treatment Market, By Devices Type

7.3.1.    Imaging Devices

7.3.1.1.    Computed Tomography Devices

7.3.1.2.    Magnetic Resonance Imaging

7.3.1.3.    X-Ray

7.3.1.4.    Others

7.3.2.    Clinical Examination Devices

7.3.3.    Monitoring Devices

7.3.3.1.    Invasive Monitoring Devices 

7.3.3.2.    Non-Invasive Monitoring Devices 

7.4.    North America Mild Traumatic Brain Injury Treatment Market, By Technique

7.4.1.    Intracranial Pressure Monitoring (ICP) 

7.4.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

7.5.    North America Mild Traumatic Brain Injury Treatment Market, By End User

7.5.1.    Hospitals

7.5.2.    Diagnostic Imaging Centers

7.5.3.    Others

7.6.    North America Mild Traumatic Brain Injury Treatment Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Devices Type

7.6.3.    By Technique

7.6.4.    By End User

8.    Latin America Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Mild Traumatic Brain Injury Treatment Market

8.2.2.    Mexico Mild Traumatic Brain Injury Treatment Market

8.2.3.    Argentina Mild Traumatic Brain Injury Treatment Market

8.2.4.    Rest of Latin America Mild Traumatic Brain Injury Treatment Market

8.3.    Latin America Mild Traumatic Brain Injury Treatment Market, By Devices Type

8.3.1.    Imaging Devices

8.3.1.1.    Computed Tomography Devices

8.3.1.2.    Magnetic Resonance Imaging

8.3.1.3.    X-Ray

8.3.1.4.    Others

8.3.2.    Clinical Examination Devices

8.3.3.    Monitoring Devices

8.3.3.1.    Invasive Monitoring Devices 

8.3.3.2.    Non-Invasive Monitoring Devices 

8.4.    Latin America Mild Traumatic Brain Injury Treatment Market, By Technique

8.4.1.    Intracranial Pressure Monitoring (ICP) 

8.4.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

8.5.    Latin America Mild Traumatic Brain Injury Treatment Market, By End User

8.5.1.    Hospitals

8.5.2.    Diagnostic Imaging Centers

8.5.3.    Others

8.6.    Latin America Mild Traumatic Brain Injury Treatment Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Devices Type

8.6.3.    By Technique

8.6.4.    By End User

9.    Europe Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Mild Traumatic Brain Injury Treatment Market

9.2.2.    Germany Mild Traumatic Brain Injury Treatment Market

9.2.3.    Italy Mild Traumatic Brain Injury Treatment Market

9.2.4.    France Mild Traumatic Brain Injury Treatment Market

9.2.5.    Spain Mild Traumatic Brain Injury Treatment Market

9.2.6.    Russia Mild Traumatic Brain Injury Treatment Market

9.2.7.    Poland Mild Traumatic Brain Injury Treatment Market

9.2.8.    BENELUX Mild Traumatic Brain Injury Treatment Market

9.2.9.    NORDIC Mild Traumatic Brain Injury Treatment Market

9.2.10.    Rest of Europe Mild Traumatic Brain Injury Treatment Market

9.3.    Europe Mild Traumatic Brain Injury Treatment Market, By Devices Type

9.3.1.    Imaging Devices

9.3.1.1.    Computed Tomography Devices

9.3.1.2.    Magnetic Resonance Imaging

9.3.1.3.    X-Ray

9.3.1.4.    Others

9.3.2.    Clinical Examination Devices

9.3.3.    Monitoring Devices

9.3.3.1.    Invasive Monitoring Devices 

9.3.3.2.    Non-Invasive Monitoring Devices 

9.4.    Europe Mild Traumatic Brain Injury Treatment Market, By Technique

9.4.1.    Intracranial Pressure Monitoring (ICP) 

9.4.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

9.5.    Europe Mild Traumatic Brain Injury Treatment Market, By End User

9.5.1.    Hospitals

9.5.2.    Diagnostic Imaging Centers

9.5.3.    Others

9.6.    Europe Mild Traumatic Brain Injury Treatment Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Devices Type

9.6.3.    By Technique

9.6.4.    By End User

10.    Asia Pacific Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Mild Traumatic Brain Injury Treatment Market

10.2.2.    India Mild Traumatic Brain Injury Treatment Market

10.2.3.    Japan Mild Traumatic Brain Injury Treatment Market

10.2.4.    Australia and New Zealand Mild Traumatic Brain Injury Treatment Market

10.2.5.    South Korea Mild Traumatic Brain Injury Treatment Market

10.2.6.    ASEAN Mild Traumatic Brain Injury Treatment Market

10.2.7.    Rest of Asia Pacific Mild Traumatic Brain Injury Treatment Market

10.3.    Asia Pacific Mild Traumatic Brain Injury Treatment Market, By Devices Type

10.3.1.    Imaging Devices

10.3.1.1.    Computed Tomography Devices

10.3.1.2.    Magnetic Resonance Imaging

10.3.1.3.    X-Ray

10.3.1.4.    Others

10.3.2.    Clinical Examination Devices

10.3.3.    Monitoring Devices

10.3.3.1.    Invasive Monitoring Devices 

10.3.3.2.    Non-Invasive Monitoring Devices 

10.4.    Asia Pacific Mild Traumatic Brain Injury Treatment Market, By Technique

10.4.1.    Intracranial Pressure Monitoring (ICP) 

10.4.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

10.5.    Asia Pacific Mild Traumatic Brain Injury Treatment Market, By End User

10.5.1.    Hospitals

10.5.2.    Diagnostic Imaging Centers

10.5.3.    Others

10.6.    Asia Pacific Mild Traumatic Brain Injury Treatment Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Devices Type

10.6.3.    By Technique

10.6.4.    By End User

11.    Middle East Mild Traumatic Brain Injury Treatment Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Mild Traumatic Brain Injury Treatment Market

11.2.2.    Israel Mild Traumatic Brain Injury Treatment Market

11.2.3.    Oman Mild Traumatic Brain Injury Treatment Market

11.2.4.    Rest of Middle East Mild Traumatic Brain Injury Treatment Market

11.3.    Middle East Mild Traumatic Brain Injury Treatment Market, By Devices Type

11.3.1.    Imaging Devices

11.3.1.1.    Computed Tomography Devices

11.3.1.2.    Magnetic Resonance Imaging

11.3.1.3.    X-Ray

11.3.1.4.    Others

11.3.2.    Clinical Examination Devices

11.3.3.    Monitoring Devices

11.3.3.1.    Invasive Monitoring Devices 

11.3.3.2.    Non-Invasive Monitoring Devices 

11.4.    Middle East Mild Traumatic Brain Injury Treatment Market, By Technique

11.4.1.    Intracranial Pressure Monitoring (ICP) 

11.4.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

11.5.    Middle East Mild Traumatic Brain Injury Treatment Market, By End User

11.5.1.    Hospitals

11.5.2.    Diagnostic Imaging Centers

11.5.3.    Others

11.6.    Middle East Mild Traumatic Brain Injury Treatment Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Devices Type

11.6.3.    By Technique

11.6.4.    By End User

12.    Africa Mild Traumatic Brain Injury Treatment Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Mild Traumatic Brain Injury Treatment Market

12.2.2.    Egypt Mild Traumatic Brain Injury Treatment Market

12.2.3.    North Africa Mild Traumatic Brain Injury Treatment Market

12.2.4.    Rest of Africa Mild Traumatic Brain Injury Treatment Market

12.3.    Africa Mild Traumatic Brain Injury Treatment Market, By Devices Type

12.3.1.    Imaging Devices

12.3.1.1.    Computed Tomography Devices

12.3.1.2.    Magnetic Resonance Imaging

12.3.1.3.    X-Ray

12.3.1.4.    Others

12.3.2.    Clinical Examination Devices

12.3.3.    Monitoring Devices

12.3.3.1.    Invasive Monitoring Devices 

12.3.3.2.    Non-Invasive Monitoring Devices 

12.4.    Africa Mild Traumatic Brain Injury Treatment Market, By Technique

12.4.1.    Intracranial Pressure Monitoring (ICP) 

12.4.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

12.5.    Africa Mild Traumatic Brain Injury Treatment Market, By End User

12.5.1.    Hospitals

12.5.2.    Diagnostic Imaging Centers

12.5.3.    Others

12.6.    Africa Mild Traumatic Brain Injury Treatment Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Devices Type

12.6.3.    By Technique

12.6.4.    By End User

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    TEVA Pharmaceutical Industries Ltd.

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Product Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Neuren Pharmaceuticals Ltd.

14.3.3.    Tenax Therapeutics

14.3.4.    IschemixInc

14.3.5.    Grace Laboratories LLC.

14.3.6.    Silver Creek Pharmaceuticals Inc.

14.3.7.    Stemedica Cell Technologies Inc.

14.3.8.    NeuroScience Pharmaceuticals

14.3.9.    Vasopharm GmbH

14.3.10.    AmarantusBioScience Holdings

14.3.11.    Banayan Biomarkers Inc.

15.    Acronyms

Select License Type

Frequently Asked Questions

The global mild traumatic brain injury treatment market in 2020 is estimated for more than US$ 65.8 Mn and expected to reach a value of US$ 93.0 Mn by 2028 with a significant CAGR of 4.4%.

The increasing number of road accidents, coupled with the growing number of vulnerable aging populations are major factors driving the growth of the global traumatic brain injuries treatment market

Mild traumatic brain injury treatment market is segmented on the basis of device type, technique, end-user, and by region.

Key players operating in the global mild traumatic brain injury treatment market include TEVA Pharmaceutical Industries Ltd., Neuren Pharmaceuticals Ltd, Tenax Therapeutics, IschemixInc, Grace Laboratories LLC., Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, NeuroScience Pharmaceuticals, Vasopharm GmbH, AmarantusBioScience Holdings, and Banayan Biomarkers Inc.